For more than 20 years, the Stem Cell Network has made strategic investments in stem cell and regenerative medicine research, helping to position Canada as a global leader in the field. As Canada’s on...

If you live with type 1 diabetes (T1D), or love someone who does, you know how much daily effort it takes to stay healthy and how urgently better treatments and cures are needed. That’s why we want to share an important update. Breakthrough T1D Canada has formally asked the federal government to partner with us […]

JDRF Clinician Investigator Fellowships are designed to attract and promote clinician scientists in the field of T1D research. These fellowships are open to medical residents who are pursuing graduate...

Find a career with Breakthrough T1D

Zimislecel is an allogeneic stem cell–derived islet-cell therapy. Data on the safety and efficacy of zimislecel in persons with type 1 diabetes are needed. We conducted a phase 1–2 study of zimisle...

A clinical trial involving adolescents with type 1 diabetes (T1D) has found a combination therapy may reduce chronic kidney disease and improve health outcomes. The findings could help guide more prec...

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

On May 5, 2025, Sanofi announced Health Canada approval of Tzield, the first disease-modifying therapy for type 1 diabetes (T1D). This is a huge win for the T1D community in that it is the first medic...

Explore Breakthrough T1D’s funding opportunities for type 1 diabetes research. Learn how we support innovative projects driving breakthroughs in T1D treatment, prevention, and cures.

Assistant Professor (tenure track) - Chromatin Regulation, Genetic Regulatory Mechanisms, Epigenetics, Epigenomics

Costs & Coverage Please note that most mental health providers typically charge a fee on a per visit basis. If you have private insurance, it may cover specific mental health services. We recommend ch...

What's up with IA2A?! Excited to share this collaborative work in Diabetologia showing that IA-2A+ is consistently linked to increased disease progression…

CanScreen T1D Research Consortium Creating Canada's First Type 1 Diabetes Screening Program Learn about what we do CanScreen T1D Research Consortium Your child’s health matters. The Canadi...

Type 1 diabetes (T1D) is a chronic metabolic disease resulting from an autoimmune destruction of pancreatic beta cells. Beta cells activate various stress responses during the development of T1D, incl...

In a crossover trial evaluating semaglutide versus placebo as an add-on to automated insulin delivery therapy in adults with type 1 diabetes, the use of semaglutide was associated with an increased pe...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce...

JDRF provides funding and support for the best and brightest minds in T1D research in Canada. Since our inception over 50 years ago, we have been part of almost major breakthrough in type 1 diabetes r...

ALT: a man wearing a beanie and a black jacket is smiling and holding a piece of food .